Key Takeaways
- US Pending Home Sales plummeted 5.4% in June, far exceeding the estimated 0.5% decline, as high mortgage rates and record home prices sidelined prospective buyers.
- Abbott Laboratories (ABT) shares surged as much as 14%, marking the stock's best performance in over two decades following favorable developments in ongoing litigation.
- Wall Street investment banking fees skyrocketed in Q2, with Goldman Sachs (GS) reporting a 55% jump and JPMorgan Chase (JPM) seeing a 30% increase driven by an "AI super-cycle" and mega-IPOs.
- Apple (AAPL) is reportedly readying an OLED iPad mini for an October launch, while updates for the entry-level iPad and iPad Air are now pushed to 2027.
- Builder confidence fell to a reading of 34 in July, the 15th consecutive month the NAHB Housing Market Index has remained below the key 40-point threshold.
Housing Sector Faces Deepening Affordability Crisis
The U.S. housing market showed significant signs of strain in June as Pending Home Sales tumbled 5.4%, a sharp reversal from the 3.8% gain seen in May. The National Association of Realtors (NAR) reported that the index fell to 76.8, as the combination of 6.49% average mortgage rates and a record median home-sale price of $408,776 effectively froze market activity.
Builder sentiment also remains in the doldrums, with the NAHB Housing Market Index dropping to 34 in July against expectations of 35. To combat falling demand, 37% of builders reported cutting prices this month, while 63% utilized sales incentives to attract buyers. Analysts note that this represents the longest stretch of depressed builder confidence since 2012, highlighting a structural shift in market accessibility.
Wall Street Capitalizes on Market Volatility and AI Boom
Major financial institutions reported a windfall in the second quarter, led by a massive resurgence in deal-making and trading activity. Goldman Sachs (GS) saw its equities revenue jump 72%, while JPMorgan Chase (JPM) and Morgan Stanley (MS) reported equity trading gains of 86% and 69%, respectively.
The surge was fueled by a "super-cycle" of investment in AI infrastructure and high-profile listings, most notably the historic IPO of SpaceX. Executives indicate that healthy pipelines and strong backlogs suggest the investment banking recovery has significant room to run through the second half of the year.
Corporate Highlights: Abbott Labs and Apple
Abbott Laboratories (ABT) experienced its largest single-day gain since 2002, with shares climbing 14%. The rally follows a series of legal updates regarding Necrotizing Enterocolitis (NEC) lawsuits, where recent jury decisions and trial orders have provided more clarity on the company's potential liability.
In the tech sector, Apple (AAPL) is moving forward with a major display overhaul for its tablet lineup. Bloomberg reports that an OLED iPad mini (code-named J510) is slated for release by October 2026. However, consumers waiting for refreshes to the iPad Air and the base-model iPad will likely have to wait until Spring 2027, as the company prioritizes the mini's transition to higher-contrast screen technology.
Geopolitical Tensions Impact Global Trade
The conflict in Eastern Europe continues to escalate, with Ukraine's Seaports Authority reporting that Russia hit Ukrainian ports 23 times during the first two weeks of July. These "massive" strikes have targeted critical infrastructure in Odesa and Mykolaiv, damaging grain silos and sunflower oil tanks belonging to major exporters like Kernel. The persistent attacks on Black Sea trade routes are threatening global food security and reducing Ukraine's ability to generate vital foreign-currency revenue.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.